Amerikaanse aandelen « Terug naar discussie overzicht

BioElectronics Cooperation (BIEL)

978 Posts, Pagina: « 1 2 3 4 5 6 ... 12 13 14 15 16 17 18 19 20 21 22 ... 45 46 47 48 49 » | Laatste
[verwijderd]
0
pfew... gelukkig gaat ie weer up...

had ik het al gehad over de 10% oppasloon??

ach dat zullen ze ook wel snappen neem ik aan.. ;-)))
[verwijderd]
0
quote:

roos1971 schreef:

ik moest smsen als ie mooi up ging, maar ehh ook als ie down ging??

nah...
denk dat je zo ff kan sms'en roos.

Volgens mij haalt die DH wel.

En volgende week verder up.

vr gr willem.
[verwijderd]
0
day high heeft ie net geraakt volgens mij... ;-)

ben al lang blij dat ie boven de 6 kwam haha
anders vond ik het wel heel nuiver..
[verwijderd]
0
Laatste 0,0625 22:02 29.800
+/- 0,0085 15,74%
Slot 0,0540 23-07-09
Open 0,0590 15:28
Hoog 0,0630 21:59
Laag 0,0551 15:47
Bied
Laat
Volume 103.782.189

Volgens binck 0,0625, maar kan nog veranderen,
staat altijd 02.10 bij in mijn port.

vr gr willem.
[verwijderd]
0
quote:

roos1971 schreef:

slot naar mijn idee 0,063
Roos dit

gaat vliegen maandag woooooooooooooooow

FREDERICK, MD--BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announce it has significantly reduced its level of convertible debt. As of the end of the June 2009 quarter, convertible debt was below $100,000 compared to approximately $910,000 as of the end of the June 2008 quarter. Since the end of the June 2009, the balance has been reduced further. Andrew Whelan, CEO of BioElectronics, Corp. provides the following updates on this and other corporate activities.

Convertible Debt Reduction -- We are fortunate to have now repaid almost all of our convertible debentures and we would expect the balances to be at or near zero over the coming weeks. The elimination of this type of debt is important as most institutional investors will not invest in companies with this type of debt in place. We now have a host of mainstream financing options available that offer the Company and its shareholders a significantly reduced cost of capital.

Export-Import Bank Guarantee -- With our convertible debt level reduction, we were able to secure a guarantee from the Export-Import Bank of the United States, which is the U.S. government's official export credit agency. This guarantee will make it significantly easier for us to secure lower cost capital to finance our growing international distribution network. This is a very positive development for BioElectronics.

Recent Quarterly Performance -- Later today, we will be releasing our March quarter financials with our June quarter numbers to follow over the next few weeks. While our revenues are still relatively small, we are beginning to see strong growth, particularly within our international markets -- we are clearly now moving out of the development stage. We have maintained very tight expense controls, which have enabled us to operate at a very small loss. For example, net loss in the March quarter was just under $36,000.

Margins -- We are very excited about the margins we are able to realize on our products. As will be seen in our financials, we operate at gross margins in excess of 70% even at relatively low revenue levels. As our volumes grow, we believe we may be able to meaningfully grow these already very strong margins.

Profitability Expectation -- With a growing international distribution base, probable FDA clearances coming over the next few months and very strong margins, we expect to be very profitable over the coming quarters as our business plan further develops and as our cost of capital continues to fall.

Clinical studies and Status of FDA Filings -- We will be conducting a conference call on Tuesday, July 28 to discuss the results of a clinical study recently completed under the direction of Dr. David Genecov. In addition, the management team will discuss the status of current FDA filings and the additional FDA filings we plan to make over the coming weeks. We hope you will join us for the call to discuss these exciting developments.

Our Priorities -- Our priorities in order of importance remain the following: 1) Completion of clinical studies, 2) FDA submissions, 3) International distribution expansion, and 4) Further development our patented, drug free ActiPatch, Allay and RecoveryRx brands. Reverse stock splits or reverse mergers are not being contemplated.

About BioElectronics Corporation

BioElectronics Corporation is the maker of ActiPatch® Therapy, RecoveryRx™ Devices, HealFast™ Therapy (www.healfasttherapy.com) and the Allay™ family of inexpensive, disposable drug-free anti-inflammatory devices. For more information please see www.BioElectronicsCorp.com.

[verwijderd]
0
[verwijderd]
0
quote:

roos1971 schreef:

even door de vertaalmachine meneer kingkong hoor haha ;-))

en ehh let s fly!!!
bijna uit de schulden , dit word mega de komende maanden
[verwijderd]
0
quote:

roos1971 schreef:

even door de vertaalmachine meneer kingkong hoor haha ;-))

en ehh let s fly!!!
Volgens mij heeft Roos dit al gelezen een paar uur geleden ?
[verwijderd]
0
haha u moet geen dubbele berichten plaatsen meneer kingkong hoor.

maar ach beter dubbel dan niet natuurlijk :-)
[verwijderd]
0
Maar wat gaat ie vanaf dinsdag doen ?

Maandag zwaar inkopen en vanaf dinsdag skyhigh ?
[verwijderd]
0
quote:

marnop schreef:

Maar wat gaat ie vanaf dinsdag doen ?

Maandag zwaar inkopen en vanaf dinsdag skyhigh ?
ehh weet niet eens wanneer de cc is dinsdag... haha
ehh voorbeurs?

zal even kijken

en ehh skyhigh natuurlijk meneer marnop haha ehh i hope ;-)
[verwijderd]
0

quote:

stampie3 schreef:

marketwire
BioElectronics Significantly Reduces Convertible Debt Levels
CEO Provides Update on Corporate Activities

* Press Release
* Source: BioElectronics Corporation
* On Friday July 24, 2009, 11:00 am EDT

BioElectronics Corp. (Pinksheets:BIEL - News), the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announce it has

vr gr willem.
[/quote]

[quote=welshterrier ]
[quote=stampie3]

marketwire
BioElectronics Significantly Reduces Convertible Debt Levels

vr gr willem.
[/quote]

zeer goede berichten hier
3x al,

hahahaha.

maar geeft niets, haha ik vond het wel grappig eigenlijk.

maar beter dubbel het nieuws dan geen nieuws.

Maar nu weet je het wel Roos ?
[verwijderd]
0
haha ja ehh had het zelfs al vaker gelezen, hier op forum maar twee keer haha derde dan overheen gezien denk ik en om google finance natuurlijk ;-))

ik dacht onze meneer kingkong komt met nieuw nieuws haha maarja toen ik het las (in het engels zelfs al, moet je nagaan hahaha) zag ik het pas ;-))

ehhh 11 am dinsdag cc

das nederlandse tijd.. vijf uur?
[verwijderd]
0


FREDERICK, MD--(Marketwire - 07/22/09) - BioElectronics Corp. (Pinksheets:BIEL - News), the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced a conference call will be held at 11AM (EDT), Tuesday, July 28th to discuss the results of a clinical study recently completed under the direction of David G. Genecov, M.D. FACS FAAP and Joel Brook, DPM, MS, FACFAS. The management team will also provide its stakeholders with an update on corporate activities and information on the status of FDA filings.

Inderdaad om 17.00 uur ned tijd.

vr gr willem.
welshterrier 5
0
Roos bedankt voor je sms, je weet het hoger weil ik graag weten, lager niet....
mooi slot idd maandag sky high
fijn weekend
[verwijderd]
0
quote:

stampie3 schreef:

Laatste 0,0625 22:02 29.800
+/- 0,0085 15,74%
Slot 0,0540 23-07-09
Open 0,0590 15:28
Hoog 0,0630 21:59
Laag 0,0551 15:47
Bied
Laat
Volume 103.782.189

Volgens binck 0,0625, maar kan nog veranderen,
staat altijd 02.10 bij in mijn port.

vr gr willem.
mooi gesloten boven de 0.0600.goed teken.volgende week verder up.
[verwijderd]
0
[verwijderd]
0
quote:

roos1971 schreef:

.....ben benieuwd waar we volgende week heen gaan :-)
benieuwT
978 Posts, Pagina: « 1 2 3 4 5 6 ... 12 13 14 15 16 17 18 19 20 21 22 ... 45 46 47 48 49 » | Laatste
Aantal posts per pagina:  20 50 100 | Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met uw e-mailadres en wachtwoord.

Direct naar Forum

Markt vandaag

 AEX
938,66  +0,08  +0,01%  12:47
 Germany40^ 22.364,90 +0,23%
 BEL 20 4.396,96 +0,63%
 Europe50^ 5.480,43 +0,36%
 US30^ 44.236,90 +0,12%
 Nasd100^ 22.093,80 +0,11%
 US500^ 6.118,58 -0,01%
 Japan225^ 38.825,50 +0,62%
 Gold spot 2.931,45 -0,26%
 EUR/USD 1,0471 -0,26%
 WTI 71,83 -0,81%
#/^ Index indications calculated real time, zie disclaimer

Stijgers

HEIJMANS KON +7,80%
Brunel +5,39%
JDE PEET'S +2,72%
JUST EAT TAKE... +2,53%
TomTom +2,51%

Dalers

PostNL -2,71%
VASTNED -1,77%
EBUSCO HOLDING -1,74%
NN Group -1,24%
Accsys -1,11%